Literature DB >> 11677007

The use of alternative medicine by patients with amyotrophic lateral sclerosis.

M Wasner1, H Klier, G D Borasio.   

Abstract

The use of complementary and alternative medicine (CAM) is increasing in all industrialised countries, especially in patients with chronic and incurable diseases. However, no data are available on the use of CAM by patients with amyotrophic lateral sclerosis (ALS). The German Association for Neuromuscular Diseases (DGM) mailed out a questionnaire on CAM to 350 ALS patients, 171 of whom completed and returned the survey (response rate 49%). The use of CAM was reported by 92 patients (54%). There were no significant demographic differences between users and nonusers. The patients used 73 different methods or substances; some tried up to 11 different treatments. The most widely used methods were: acupuncture (47%), homeopathy (40%), naturopathy (24%) and esoteric treatments (20%). The lower the patients' expectations from CAM, the better was the subjectively perceived effect. In most cases (60%), alternative treatments were performed by a physician. Patients spent on average 4000 (approximately US$4500) on CAM, generally without reimbursement. CAM is most often used in addition to conventional treatments and may be part of the patients' coping strategy. Open communication between patients and physicians is essential to warn the patients of medically or financially hazardous treatments. Future research should look at the possible palliative effects of CAM on symptom control and quality of life of patients and families.

Entities:  

Mesh:

Year:  2001        PMID: 11677007     DOI: 10.1016/s0022-510x(01)00615-3

Source DB:  PubMed          Journal:  J Neurol Sci        ISSN: 0022-510X            Impact factor:   3.181


  14 in total

1.  Riluzole treatment in advanced ALS.

Authors:  Gian Domenico Borasio
Journal:  J Neurol       Date:  2002-05       Impact factor: 4.849

2.  Complementary and alternative medicine use among US adults with common neurological conditions.

Authors:  Rebecca Erwin Wells; Russell S Phillips; Steven C Schachter; Ellen P McCarthy
Journal:  J Neurol       Date:  2010-06-11       Impact factor: 4.849

Review 3.  Complementary and Alternative Therapies in Amyotrophic Lateral Sclerosis.

Authors:  Richard S Bedlack; Nanette Joyce; Gregory T Carter; Sabrina Paganoni; Chafic Karam
Journal:  Neurol Clin       Date:  2015-09-08       Impact factor: 3.806

Review 4.  Complementary and alternative medicine and coping in neuroimmunological diseases.

Authors:  A Apel; B Greim; U K Zettl
Journal:  J Neurol       Date:  2007-05       Impact factor: 4.849

Review 5.  Economic Studies in Motor Neurone Disease: A Systematic Methodological Review.

Authors:  Alan Moore; Carolyn A Young; Dyfrig A Hughes
Journal:  Pharmacoeconomics       Date:  2017-04       Impact factor: 4.981

6.  Perspective: Untangling the ALS X-Files.

Authors:  Richard Bedlack
Journal:  Nature       Date:  2017-10-18       Impact factor: 49.962

7.  Use of complementary and alternative medicine among persons with diabetes mellitus: results of a national survey.

Authors:  Gloria Y Yeh; David M Eisenberg; Roger B Davis; Russell S Phillips
Journal:  Am J Public Health       Date:  2002-10       Impact factor: 9.308

Review 8.  Recent advances in amyotrophic lateral sclerosis research.

Authors:  Serge Przedborski; Hiroshi Mitsumoto; Lewis P Rowland
Journal:  Curr Neurol Neurosci Rep       Date:  2003-01       Impact factor: 5.081

9.  The effects of bee venom acupuncture on the central nervous system and muscle in an animal hSOD1G93A mutant.

Authors:  MuDan Cai; Sun-Mi Choi; Eun Jin Yang
Journal:  Toxins (Basel)       Date:  2015-03-13       Impact factor: 4.546

10.  Complementary and Alternative Medicine Use in Amyotrophic Lateral Sclerosis Cases in South Korea.

Authors:  Sungha Kim; Sujeong Mun; Jeonghwan Park; Sunmi Choi; Sanghun Lee; Sungchul Kim
Journal:  Evid Based Complement Alternat Med       Date:  2019-07-25       Impact factor: 2.629

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.